EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Therapeutic Efficacy and Clinical Advances in Debridement, Antibiotics, and Implant Retention for Acute Periprosthetic Joint Infection Following Total Knee Arthroplasty

Suvarna Jyothi Navuduri, Pranavi Burugu, Sekhar Vijay Ganguluri

Journal of Pharma Insights and Research · 05.02.2026 · 4 (1) · 144-153

DOI: 10.69613/5259jm26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharma Insights and Research, online erschienen am 05.02.2026. Verfasst von Suvarna Jyothi Navuduri und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Periprosthetic joint infection (PJI) is a primary cause of failure in total knee arthroplasty (TKA), requiring careful management techniques to preserve joint function and mitigate surgical morbidity. Debridement, Antibiotics, and Implant Retention (DAIR) serves as a critical, joint-preserving intervention for early postoperative and acute hematogenous infections. Clinical success with the DAIR protocol ranges between 41% and 92%, a variance heavily influenced by the timing of intervention, the virulence of causative pathogens, and the physiological status of the host. Optimal outcomes are typically achieved when surgical intervention occurs within a narrow window of 4 to 6 weeks following the onset of symptoms, particularly when combined with the exchange of modular components. Conversely, infections involving highly virulent strains such as Staphylococcus aureus or those occurring in elderly patients with significant systemic comorbidities often result in higher rates of treatment failure. The integration of modern diagnostic guidelines, such as the 2021 European Bone and Joint Infection Society (EBJIS) criteria, has refined the precision of diagnostic staging and therapeutic planning. While targeted antibiotic regimens specifically those utilizing rifampin for staphylococcal biofilms are essential components of the protocol, the ideal duration of therapy remains a subject of active investigation. Emerging surgical techniques, including the use of antibiotic pearls and specialized antiseptic irrigation solutions, show promise in enhancing biofilm eradication. Although chronic infections remain a relative contraindication, the application of DAIR in acute care offers superior functional recovery and patient satisfaction compared to more invasive multi-stage revision procedures

Zitieren

APA

Navuduri, S. J., Burugu, P., & Ganguluri, S. V. (2026). Therapeutic Efficacy and Clinical Advances in Debridement, Antibiotics, and Implant Retention for Acute Periprosthetic Joint Infection Following Total Knee Arthroplasty. Journal of Pharma Insights and Research, 4(1), 144-153. https://doi.org/10.69613/5259jm26

Vancouver

Navuduri SJ, Burugu P, Ganguluri SV. Therapeutic Efficacy and Clinical Advances in Debridement, Antibiotics, and Implant Retention for Acute Periprosthetic Joint Infection Following Total Knee Arthroplasty. Journal of Pharma Insights and Research. 2026;4(1):144-153. doi:10.69613/5259jm26

BibTeX
@article{Navuduri2026,
  author = {Navuduri, Suvarna Jyothi and Burugu, Pranavi and Ganguluri, Sekhar Vijay},
  title = {Therapeutic Efficacy and Clinical Advances in Debridement, Antibiotics, and Implant Retention for Acute Periprosthetic Joint Infection Following Total Knee Arthroplasty},
  journal = {Journal of Pharma Insights and Research},
  year = {2026},
  volume = {4},
  number = {1},
  pages = {144--153},
  doi = {10.69613/5259jm26}
}
Kostenlos starten →